Physician profile
Steven D Wise
NPI 1659327468
$3,148.31
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $554 · 2021: $680 · 2022: $1,247.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $643.80 | 2019-2022 | |
| Amgen INC. | $388.29 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $287.78 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $231.57 | 2021-2022 | |
| Lilly USA, LLC | $196.72 | 2019-2022 | |
| Corcept Therapeutics | $168.58 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $104.08 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.66 | 2019-2022 | |
| Dexcom, INC. | $85.35 | 2020-2022 | |
| Ultragenyx Pharmaceutical INC. | $68.16 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $66.86 | 2019-2020 | |
| Ibsa Pharma INC. | $58.11 | 2019-2022 | |
| Abbott Laboratories | $47.42 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $46.67 | 2022 | |
| Medtronic, INC. | $45.63 | 2021-2022 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $43.91 | 2022 | |
| Amryt Pharma Holdings LTD | $41.40 | 2022 | |
| Radius Health, INC. | $40.04 | 2020 | |
| Merck Sharp & Dohme LLC | $39.09 | 2020 | |
| Nevro Corp. | $36.68 | 2022 | |
| Insulet Corporation | $36.14 | 2021 | |
| Endo Pharmaceuticals INC. | $35.67 | 2020 | |
| Sanofi-Aventis U.S. LLC | $33.98 | 2020 | |
| Cequr Corporation | $32.60 | 2022 | |
| Shire North American Group INC | $29.08 | 2019 | |
| Medtronic Minimed, INC. | $27.75 | 2020 | |
| Abbvie INC. | $25.89 | 2019-2021 | |
| Grt US Holding, INC. | $23.45 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.65 | 2022 | |
| Aurinia Pharma U.S., INC. | $18.92 | 2022 | |
| Esperion Therapeutics, INC. | $18.52 | 2022 | |
| Acerus Pharmaceuticals Corporation | $18.29 | 2020 | |
| Vivus LLC | $16.22 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $14.48 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.33 | 2019 | |
| Antares Pharma, INC. | $12.69 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.10 | 2019 | |
| Amarin Pharma, INC. | $12.02 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.73 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wise listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.